References
- Akhter N, Wilson A, Arefanian H, Thomas R, Kochumon S, Al-Rashed F, Abu-Farha M, Al-Madhoun A, Al-Mulla F, Ahmad R, Sindhu S. Endoplasmic reticulum stress promotes the expression of TNF-alpha in THP-1 cells by mechanisms involving ROS/CHOP/HIF-1alpha and MAPK/NF-kappaB pathways. Int J Mol Sci 24, 15186, 2023.
- Amin-Wetzel N, Saunders RA, Kamphuis MJ, Rato C, Preissler S, Harding HP, Ron D. A J-protein co-chaperone recruits BiP to monomerize IRE1 and repress the unfolded protein response. Cell 171, 1625–1637, 2017.
- Auf G, Jabouille A, Delugin M, Guerit S, Pineau R, North S, Platonova N, Maitre M, Favereaux A, Vajkoczy P, Seno M, Bikfalvi A, Minchenko D, Minchenko O, Moenner M. High epiregulin expression in human U87 glioma cells relies on IRE1a and promotes autocrine growth through EGF receptor. BMC Cancer 13, 597, 2013.
- Avitabile E, Bedognetti D, Ciofani G, Bianco A, Delogu LG. How can nanotechnology help the fight against breast cancer? Nanoscale 10, 11719–11731, 2018.
- Babakhanlou R, DiNardo C, Borthakur G. IDH2 mutations in acute myeloid leukemia. Leuk Lymphoma 64, 1733–1741, 2023.
- Barberet P, Chevet E, Dupuy D, Delville MH, Seznec H. In situ quantification of diverse titanium dioxide nanoparticles unveils selective endoplasmic reticulum stress-dependent toxicity. Nanotoxicology 11, 134–145, 2017.
- Block I, Muller C, Sdogati D, Pedersen H, List M, Jaskot AM, Damkjar Syse S, Lund Hansen P, Schmidt S, Chris-tiansen H, Casella C, Bering Olsen S, Blomstrom MM, Riedel A, Thomassen M, Kruse TA, Hansen SWK, Kioschis P, Mollenhauer J. CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3. Oncogene 38, 4560–4573, 2019.
- Cao Y, Long J, Liu L, He T, Jiang L, Zhao C, Li Z. A review of endoplasmic reticulum (ER) stress and nanoparticle (NP) exposure. Life Sci 186, 33–42, 2017.
- Cellot G, Franceschi Biagioni A, Ballerini L. Nanomedicine and graphene-based materials: advanced technologies for potential treatments of diseases in the developing nervous system. Pediatr Res 92, 71–79, 2022.
- Chen L, Li J, Chen Z, Gu Z, Yan L, Zhao F, Zhang A. Toxicological evaluation of graphene-family nanomaterials. J Nanosc Nanotechnol 20, 1993–2006, 2020.
- Chen R, Huo L, Shi X, Bai R, Zhang Z, Zhao Y, Chang Y, Chen C. Endoplasmic reticulum stress induced by zinc oxide nanoparticles is an earlier biomarker for nanotoxicological evaluation. ACS Nano 8, 2562–2574, 2014.
- Chiritoiu M, Chiritoiu GN, Munteanu CVA, Pastrama F, Ivessa NE, Petrescu SM. EDEM1 drives misfolded protein degradation via ERAD and exploits ER-phagy as back-up mechanism when ERAD is impaired. Int J Mol Sci 21, 3468, 2020.
- Cruces E, Barrios AC, Cahue YP, Januszewski B, Gilbertson LM, Perreault F. Similar toxicity mechanisms between graphene oxide and oxidized multi-walled carbon nanotubes in Microcystis aeruginosa. Chemosphere 265, 129137, 2021.
- Cui G, Wu J, Lin J, Liu W, Chen P, Yu M, Zhou D, Yao G. Graphene-based nanomaterials for breast cancer treatment: promising therapeutic strategies. J Nanobiotechnology 19, 211, 2021.
- Dash BS, Jose G, Lu YJ, Chen JP. Functionalized reduced graphene oxide as a versatile tool for cancer therapy. Int J Mol Sci 22, 2989, 2021.
- Dong H, Jin M, Liu Z, Xiong H, Qiu X, Zhang W, Guo Z. In vitro and in vivo brain-targeting chemo-photothermal therapy using graphene oxide conjugated with transferrin for gliomas. Lasers Med Sci 31, 1123–1131, 2016.
- Fadeel B, Bussy C, Merino S, Vazquez E, Flahaut E, Mouchet F, Evariste L, Gauthier L, Koivisto AJ, Vogel U, Martin C, Delogu LG, Buerki-Thurnherr T, Wick P, Beloin-Saint-Pierre D, Hischier R, Pelin M, Candotto Carniel F, Tretiach M, Cesca F, Benfenati F, Scaini D, Ballerini L, Kostarelos K, Prato M, Bianco A. Safety assessment of graphene-based materials: focus on human health and the environment. ACS Nano 12, 10582–10620, 2018.
- Guan R, Peng L, Wang D, He H, Wang D, Zhang R, Wang H, Hao H, Zhang J, Song H, Sui S, Meng X, Cui X, Bai J, Sun W, Fu S, Yu J. Decreased TOB1 expression and increased phosphorylation of nuclear TOB1 promotes gastric cancer. Oncotarget 8, 75243–75253, 2017.
- Hu H, Li L, Guo Q, Zong H, Yan Y, Yin Y, Wang Y, Oh Y, Feng Y, Wu Q, Gu N. RNA sequencing analysis shows that titanium dioxide nanoparticles induce endoplasmic reticulum stress, which has a central role in mediating plasma glucose in mice. Nanotoxicology 12, 341–356, 2018.
- Itoo AM, Vemula SL, Gupta MT, Giram M.V, Kumar SA, Ghosh B, Biswas S. Multifunctional graphene oxide nanoparticles for drug delivery in cancer. J Control Release 350, 26–59, 2022.
- Jia PP, Sun T, Junaid M, Yang L, Ma YB, Cui ZS, Wei DP, Shi HF, Pei DS. Nanotoxicity of different sizes of graphene (G) and graphene oxide (GO) in vitro and in vivo. Environ Pollut 247, 595–606, 2019.
- Kim HY, Kim YM, Hong S. DNAJB9 suppresses the metastasis of triple-negative breast cancer by promoting FBXO45-mediated degradation of ZEB1. Cell Death Dis 12, 461, 2021.
- Ku HC, Cheng, CF. Master regulator activating transcription factor 3 (ATF3) in metabolic homeostasis and cancer. Front Endocrinol (Lausanne) 11, 556, 2020.
- Lee HJ, Kim JM, Kim KH, Heo JI, Kwak SJ, Han JA. Genotoxic stress/p53-induced DNAJB9 inhibits the pro-apoptot-ic function of p53. Cell Death Differ 22, 86–95, 2015.
- Li T, Su L, Lei Y, Liu X, Zhang Y, Liu X. DDIT3 and KAT2A proteins regulate TNFRSF10A and TNFRSF10B expression in endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells. J Biol Chem 290, 11108–11118, 2015.
- Li J, Zeng H, Zeng Z, Zeng Y, Xie T. Promising graphene-based nanomaterials and their biomedical applications and potential risks: A comprehensive review. ACS Biomater Sci Eng 7, 5363–5396, 2021a.
- Li X, Gracilla D, Cai L, Zhang M, Yu X, Chen X, Zhang J, Lon X, Ding HF, Yan C. ATF3 promotes the serine synthesis pathway and tumor growth under dietary serine restriction. Cell Rep 36, 109706, 2021b.
- Liu X, Yang C, Chen P, Zhang L, Cao Y. The uses of transcriptomics and lipidomics indicated that direct contact with graphene oxide altered lipid homeostasis through ER stress in 3D human brain organoids. Sci Total Environ 849, 157815, 2022.
- Lv Q, Xing S, Li Z, Li J, Gong P, Xu X, Chang L, Jin X, Gao F, Li W, Zhang G, Yang J, Zhang X. Altered expression levels of IDH2 are involved in the development of colon cancer. Exp Therap Med 4, 801–806, 2012.
- Malhotra N, Villaflores OB, Audira G, Siregar P, Lee JS, Ger TR, Hsiao CD. Toxicity studies on graphene-based nanomaterials in aquatic organisms: current understanding. Molecules 25, 3618, 2020.
- Mendonca MC, Soares ES, de Jesus MB, Ceragioli HJ, Ferreira MS, Catharino RR, da Cruz-Hofling MA. Reduced graphene oxide induces transient blood-brain barrier opening: an in vivo study. J Nanobiotechnology 13, 78, 2015.
- Minchenko OH, Tsymbal DO, Khita OO, Minchenko DO. Inhibition of ERN1 signaling is important for the suppression of tumor growth. Clin Cancer Drugs 8, 27–38, 2021.
- Minchenko DO, Rudnytska OV, Khita OO, Kulish YV, Viletska YM, Halkin OV, Danilovskyi SV, Ratushna OO, Minchenko OH. Expression of DNAJB9 and some other genes is more sensitive to SWCNTs in normal human astrocytes than glioblastoma cells. Endocr Regul 57, 162–172, 2023.
- Minchenko OH, Khita OO, Krasnytska DA, Viletska YM, Rudnytska OV, Hnatiuk OS, Minchenko DO. ERN1 knockdown affects the expression of TGIF1 and other homeobox genes in U87MG glioblastoma cells. Arch Biochem Biophys 758, 110073, 2024.
- Papaioannou A, Higa A, Jegou G, Jouan F, Pineau R, Saas L, Avril T, Pluquet O, Chevet E. Alterations of EDEM1 functions enhance ATF6 pro-survival signaling. FEBS J 285, 4146–4164, 2018.
- Perrone M, Chiodoni C, Lecchi M, Botti L, Bassani B, Piva A, Jachetti E, Milani M, Lecis D, Tagliabue E, Verderio P, Sangaletti S, Colombo MP. ATF3 reprograms the bone marrow niche in response to early breast cancer transformation. Cancer Res 83, 117–129, 2023.
- Rhazouani A, Gamrani H, El Achaby M, Aziz K, Gebrati L, Uddin MS, Aziz F. Synthesis and toxicity of graphene oxide nanoparticles: A literature review of in vitro and in vivo studies. Biomed Res Int 2021, 5518999, 2021.
- Rozpedek W, Pytel D, Mucha B, Leszczynska H, Diehl JA, Majsterek I. The role of the PERK/eIF2α/ATF4/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress. Curr Mol Med 16, 533–544, 2016.
- Rudnytska OV, Khita OO, Minchenko DO, Tsymbal DO, Yefimova YV, Sliusar MY, Minchenko OH. The low doses of SWCNTs exhibit a genotoxic effect on the normal human astrocytes by disrupting the functional integrity of the genome. Curr Res Toxicol 2, 64–71, 2021.
- Rudnytska OV, Kulish YV, Khita OO, Minchenko DO, Tsymbal DO, Viletska YM, Sliusar MY, Trufanova DD, Minchenko OH. Exposure to nanographene oxide induces gene expression dysregulation in normal human astrocytes. Endocr Regul 56, 216–226, 2022.
- Sasai K, Akagi T, Aoyanagi E, Tabu K, Kaneko S, Tanaka S. O6-methylguanine-DNA methyltransferase is down-regulated in transformed astrocyte cells: implications for anti-glioma therapies. Mol Cancer 6, 36, 2007.
- Sharma H, Mondal S. Functionalized graphene oxide for chemotherapeutic drug delivery and cancer treatment: A promising material in nanomedicine. Int J Mol Sci 21, 6280, 2020.
- Shigeta K, Hasegawa M, Hishiki T, Naito Y, Baba Y, Mikami S, Matsumoto K, Mizuno R, Miyajima A, Kikuchi E, Saya H, Kosaka T, Oya M. IDH2 stabilizes HIF-1alpha-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer. EMBO J 42, e110620, 2023.
- Simon M, Saez G, Muggiolu G, Lavenas M, Le Trequesser Q, Michelet C, Deves G, Barberet P, Chevet E, Dupuy D, Delville MH, Seznec H. In situ quantification of diverse titanium dioxide nanoparticles unveils selective endoplasmic reticulum stress-dependent toxicity. Nanotoxicology 11, 134–145, 2017.
- Tang Q, Ren L, Liu J, Li W, Zheng X, Wang J, Du G. Withaferin A triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4-ATF3-CHOP axis. Cell Prolif 53, e12706, 2020.
- Tao J, Gu P, Lai H, Peng H, Guo Z, Yuan Y, Yu X, Shen X, Liu J, Xier Z, Li G, Yang Y. TXLNG improves insulin resistance in obese subjects in vitro and in vivo by inhibiting ATF4 transcriptional activity. Mol Cell Endocrinol 568–569, 111928, 2023.
- Tonelli FM, Goulart VA, Gomes KN, Ladeira MS, Santos AK, Lorençon E, Ladeira LO, Resende RR. Graphene-based nanomaterials: biological and medical applications and toxicity. Nanomedicine (Lond) 10, 2423–2450, 2015.
- Wang D, Li Y, Sui S, Cai M, Dong K, Wang P, Liang X, Fu S, Yu J. Involvement of TOB1 on autophagy in gastric cancer AGS cells via decreasing the activation of AKT/mTOR signaling pathway. PeerJ 10, e12904, 2022.
- Wolford CC, McConoughey SJ, Jalgaonkar SP, Leon M, Merchant AS, Dominick JL, Yin X, Chang Y, Zmuda EJ, O’Toole SA, Millar EK, Roller SL, Shapiro CL, Ostrowski MC, Sutherland RL, Hai T. Transcription factor ATF3 links host adaptive response to breast cancer metastasis. J Clin Invest 123, 2893–2906, 2013.
- Wortel IMN, van der Meer LT, Kilberg MS, van Leeuwen FN. Surviving stress: modulation of ATF4-mediated stress responses in normal and malignant cells. Trends Endocrinol Metab 28, 794–806, 2017.